company background image
1498 logo

PuraPharm SEHK:1498 Stock Report

Last Price

HK$0.76

Market Cap

HK$300.2m

7D

8.6%

1Y

-30.9%

Updated

08 Oct, 2024

Data

Company Financials

PuraPharm Corporation Limited

SEHK:1498 Stock Report

Market Cap: HK$300.2m

1498 Stock Overview

An investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally.

1498 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

PuraPharm Corporation Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PuraPharm
Historical stock prices
Current Share PriceHK$0.76
52 Week HighHK$1.15
52 Week LowHK$0.63
Beta0.15
11 Month Change8.57%
3 Month Change4.11%
1 Year Change-30.91%
33 Year Change-5.00%
5 Year Change-42.86%
Change since IPO-80.16%

Recent News & Updates

Recent updates

Risks To Shareholder Returns Are Elevated At These Prices For PuraPharm Corporation Limited (HKG:1498)

Feb 06
Risks To Shareholder Returns Are Elevated At These Prices For PuraPharm Corporation Limited (HKG:1498)

Is PuraPharm (HKG:1498) A Risky Investment?

Sep 28
Is PuraPharm (HKG:1498) A Risky Investment?

PuraPharm (HKG:1498) Has Debt But No Earnings; Should You Worry?

Nov 02
PuraPharm (HKG:1498) Has Debt But No Earnings; Should You Worry?

Is PuraPharm (HKG:1498) A Risky Investment?

Aug 23
Is PuraPharm (HKG:1498) A Risky Investment?

PuraPharm's (HKG:1498) Profits Appear To Have Quality Issues

Apr 01
PuraPharm's (HKG:1498) Profits Appear To Have Quality Issues

How Much Is PuraPharm Corporation Limited (HKG:1498) Paying Its CEO?

Dec 27
How Much Is PuraPharm Corporation Limited (HKG:1498) Paying Its CEO?

Shareholder Returns

1498HK PharmaceuticalsHK Market
7D8.6%4.2%0.4%
1Y-30.9%29.7%18.4%

Return vs Industry: 1498 underperformed the Hong Kong Pharmaceuticals industry which returned 37.7% over the past year.

Return vs Market: 1498 underperformed the Hong Kong Market which returned 30.6% over the past year.

Price Volatility

Is 1498's price volatile compared to industry and market?
1498 volatility
1498 Average Weekly Movement6.0%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement8.7%
10% most volatile stocks in HK Market18.2%
10% least volatile stocks in HK Market4.3%

Stable Share Price: 1498 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 1498's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1998525Abraham Chanwww.purapharm.com

PuraPharm Corporation Limited, an investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Oncozac, Haveron, and Immuzac brand names.

PuraPharm Corporation Limited Fundamentals Summary

How do PuraPharm's earnings and revenue compare to its market cap?
1498 fundamental statistics
Market capHK$300.24m
Earnings (TTM)-HK$87.09m
Revenue (TTM)HK$419.41m

0.7x

P/S Ratio

-3.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1498 income statement (TTM)
RevenueHK$419.41m
Cost of RevenueHK$194.76m
Gross ProfitHK$224.65m
Other ExpensesHK$311.74m
Earnings-HK$87.09m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.22
Gross Margin53.56%
Net Profit Margin-20.77%
Debt/Equity Ratio289.5%

How did 1498 perform over the long term?

See historical performance and comparison